← Back to catalogue

Contour® Next

FDA UDI

Class I (US FDA UDI)

by Ascensia Diabetes Care Us Inc.

Identity

Trade Name
CONTOUR® NEXT FDA UDI
Generic Name
Glucose monitoring system IVD, home-use FDA UDI
Device Name
Control Solution - Level 1. 1 x 2.5 mL. FDA UDI
Model / Reference
7315 FDA UDI
Description
Control Solution - Level 1. 1 x 2.5 mL. FDA UDI

Identifiers

Catalog Number
83624826 FDA UDI
Primary DI / UDI-DI
10301937315012 FDA UDI
510(k) Number
K121190 FDA UDI
K151742 FDA UDI
K160430 FDA UDI
K160682 FDA UDI
K162336 FDA UDI
K191286 FDA UDI
K193407 FDA UDI
K210687 FDA UDI
K223293 FDA UDI
K241787 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Glucose monitoring system IVD, home-use FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glucose monitoring system IVD, home-use

Contour® Next by Ascensia Diabetes Care Us Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glucose monitoring system IVD, home-use.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1b0add37-248b-4793-b13c-160612f45feb 37 fields · synced Jun 8, 2026